LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.71 | 27.76 | 2354 | 2877 | 0.8180 | 0.9409 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.71 | 27.76 | 196 | 2877 | 0.0681 | 0.3390 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.71 | 27.76 | 2689 | 2877 | 0.9345 | 0.9799 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.41 | 27.76 | 9 | 3105 | 0.0029 | -0.1525 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.41 | 27.76 | 2782 | 3105 | 0.8958 | 0.9679 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.41 | 27.76 | 232 | 3105 | 0.0747 | 0.3661 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.41 | 27.76 | 2824 | 3105 | 0.9093 | 0.9723 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.11 | 27.76 | 9 | 3331 | 0.0027 | -0.1505 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.11 | 27.76 | 3145 | 3331 | 0.9440 | 0.9834 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.11 | 27.76 | 263 | 3331 | 0.0789 | 0.3848 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.11 | 27.76 | 3018 | 3331 | 0.9059 | 0.9716 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 42.81 | 27.76 | 9 | 3596 | 0.0025 | -0.1483 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 42.81 | 27.76 | 3362 | 3596 | 0.9349 | 0.9809 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 42.81 | 27.76 | 297 | 3596 | 0.0826 | 0.4018 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 42.81 | 27.76 | 3261 | 3596 | 0.9068 | 0.9723 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 44.52 | 27.76 | 10 | 3884 | 0.0026 | -0.1334 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 44.52 | 27.76 | 3546 | 3884 | 0.9129 | 0.9746 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 44.52 | 27.76 | 319 | 3884 | 0.0821 | 0.4085 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 44.52 | 27.76 | 3461 | 3884 | 0.8910 | 0.9679 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.22 | 27.76 | 9 | 4125 | 0.0022 | -0.1445 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.22 | 27.76 | 3739 | 4125 | 0.9064 | 0.9730 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.22 | 27.76 | 337 | 4125 | 0.0817 | 0.4134 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.22 | 27.76 | 3757 | 4125 | 0.9108 | 0.9743 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.93 | 27.76 | 9 | 4421 | 0.0020 | -0.1427 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.93 | 27.76 | 3955 | 4421 | 0.8945 | 0.9698 | MN20160318_Q01 | C22 |